Login / Signup

Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.

Ryosuke SaikiKan KatayamaYosuke HirabayashiKeiko OdaMika FujimotoTomohiro MurataAyako NakajimaKaoru Dohi
Published in: BMC nephrology (2021)
Tocilizumab might be a treatment option for secondary membranous nephropathy associated with Castleman's disease.
Keyphrases
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • rheumatoid arthritis patients
  • combination therapy
  • disease activity